Hydrocodone/paracetamol
Hydrocodone/paracetamol (also known as hydrocodone/acetaminophen) is the combination of the pain medications hydrocodone and paracetamol (acetaminophen). It is used to treat moderate to severe pain. It is taken by mouth. Recreational use is common in the United States.
Combination of | |
---|---|
Hydrocodone | Opioid analgesic |
Paracetamol | Anilide analgesic |
Clinical data | |
Trade names | Lorcet, Norco, Vicodin, others |
Other names | Hydrocodone/acetaminophen, hydrocodone/APAP |
AHFS/Drugs.com | Professional Drug Facts |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | >80% |
Metabolism | Hydrocodone: extensively liver, primarily CYP3A4; /Paracetamol: liver, CYP2E1 |
Elimination half-life | for hydrocodone: 228–294 mins (3.8–4.9 hrs); for paracetamol: 120–240 mins (2–4 hrs) |
Excretion | for hydrocodone: urinary; for paracetamol: urinary (10–15% unchanged) |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
(what is this?) (verify) |
Common side effects include dizziness, sleepiness, constipation, and vomiting. Serious side effects include addiction, decreased rate of breathing, low blood pressure, serotonin syndrome, severe allergic reactions, and liver failure. Use during pregnancy may harm the fetus. Use with alcohol is not recommended. Hydrocodone works by binding to the mu-opioid receptor. How paracetamol works is unclear but may involve blocking the creation of prostaglandins.
Hydrocodone/paracetamol was approved for medical use in the United States in 1982. In the United States, it is a schedule II controlled substance. In 2021, it was the twentieth most commonly prescribed medication in the United States, with more than 26 million prescriptions. It is not available in the United Kingdom, though the combination codeine/paracetamol (co-codamol) is. It is sold under the brand names Vicodin and Norco among others.